Sarah Gehlert, Ph.D.

Dr. Sarah Gehlert, Ph.D.

University of Southern California

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2018 in Cancer Causes & Control
Verified
Journal Article
Open access
PDF file
LDLorraine T. Dean
Lorraine T. Dean
Sarah Gehlert, Ph.D.Sarah Gehlert, Ph.D.
Sarah Gehlert, Ph.D.
MNMarian L Neuhouser
Marian L Neuhouser
AOApril Oh
April Oh
Krista ZanettiKrista Zanetti
Krista Zanetti
KSKathryn H. H Schmitz
Kathryn H. H Schmitz
Greater attention to social factors, such as race/ethnicity, socioeconomic position, and others, are needed across the cancer continuum, including breast cancer, given differences in tumor biology and genetic variants have not completely explained the persistent Black/White breast cancer mortality disparity. In this commentary, we use examples in breast cancer risk assessment and survivorship to demonstrate how the failure to appropriately incorporate social factors into the design, recruitment, and analysis of research studies has resulted in missed opportunities to reduce persistent cancer disparities. The conclusion offers recommendations for how to better document and use information on social factors in cancer research and care by (1) increasing education and awareness about the importance of inclusion of social factors in clinical research; (2) improving testing and documentation of social factors by incorporating them into journal guidelines and reporting stratified results; and (3) including social factors to refine extant tools that assess cancer risk and assign cancer care. Implementing the recommended changes would enable more effective design and implementation of interventions and work toward eliminating cancer disparities by accounting for the social and environmental contexts in which cancer patients live and are treated.

1 July 2020 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
LPLisa M. Pollack
Lisa M. Pollack
MOMargaret A. Olsen
Margaret A. Olsen
Sarah Gehlert, Ph.D.Sarah Gehlert, Ph.D.
Sarah Gehlert, Ph.D.
SCSu-Hsin Chang
Su-Hsin Chang
JLJerry L. Lowder
Jerry L. Lowder

Sarah Gehlert, Ph.D.Sarah Gehlert, Ph.D.
Sarah Gehlert, Ph.D.
MCMark Clanton
Mark Clanton
OGon behalf of the Shift Work and Breast Cancer Strategic Advisory Group
on behalf of the Shift Work and Breast Cancer Strategic Advisory Group
The rates of shift work outside of daylight hours have increased in recent years, and nighttime shift work is now considered a potential carcinogenic occupational exposure. Light at night exposure, lower melatonin production, and the production of stress-related mediators disrupt normal sleep–wake cycles. Women who work lower-wage jobs and part-time workers whose shifts are determined entirely by their supervisors (rotating shifts) may be subject to stress related to efforts to align childcare and other needs with the unpredictable nature of rotating shift work. The causal link between breast cancer and the sleep cycle or circadian disruption are yet to be established; however, disruption of the circadian cycles by light at night exposure or chronic exposure to stress-related mediators have all been linked to the increased risk of breast cancer. We review the existing literature on shift work and breast cancer, identify knowledge gaps, and suggest future directions for research.

1 November 2010 in Health & Social Work
Verified
Journal Article
Closed access
PDF file
Sarah Gehlert, Ph.D.Sarah Gehlert, Ph.D.
Sarah Gehlert, Ph.D.
RCRobert Coleman
Robert Coleman
Although much attention has been paid to health disparities in the past decades, interventions to ameliorate disparities have been largely unsuccessful. One reason is that the interventions have not been culturally tailored to the disparity populations whose problems they are meant to address. Community-engaged research has been successful in improving the outcomes of racial and ethnic minority groups and thus has great potential for decreasing between-group health disparities. In this article, the authors argue that a type of community-engaged research, community-based participatory research (CBPR),is particularly useful for social workers doing health disparities research because of its flexibility and degree of community engagement. After providing an overview of community research, the authors define the parameters of CBPR, using their own work in African American and white disparities in breast cancer mortality as an example of its application. Next, they outline the inherent challenges of CBPR to academic and community partnerships. The authors end with suggestions for developing and maintaining successful community and academic partnerships.

21 May 2021 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
Sarah Gehlert, Ph.D.Sarah Gehlert, Ph.D.
Sarah Gehlert, Ph.D.
DHDarrell Hudson
Darrell Hudson
TSTina Sacks
Tina Sacks
Breast cancer is the most commonly experienced cancer among women. Its high rates of incidence and survival mean that a number of women will live it for periods of their lifetimes. Group differences in breast cancer incidence and mortality occur by race and ethnicity. For example, while white women are slightly more likely to be diagnosed with breast cancer, Black women are 40% more likely to die from the disease. In this article, rather than focusing the discussion on individual-level factors like health behaviors that have the potential to blame Black women and those living in poverty for their conditions, we view breast cancer disparities through the lens of Critical Race Theory, taking a historical perspective. This allows us to delve beyond individual risk factors to explore social determinants of breast cancer disparities at the population level, paying special attention to the myriad ways in which social factors, notably views of race and discriminatory public policies, over time have contributed to the disproportionate breast cancer mortality experienced by Black women. We suggest ways of addressing breast cancer disparities, including methods of training healthcare professionals and public policy directions, that include rather than marginalize Black and lower socioeconomic status women.

1 September 2011 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
Sarah Gehlert, Ph.D.Sarah Gehlert, Ph.D.
Sarah Gehlert, Ph.D.
GCGraham A Colditz
Graham A Colditz
Background: The first 20 years of publication of Cancer Epidemiology, Biomarkers & Prevention occurred during a period of increased attention to health disparities and advances in knowledge about their determinants. Yet, despite clear documentation of disparities and advanced understanding of determinants, we have made little headway in reducing disparities at the population level. Multilevel models, such as one produced by the Centers for Population Health and Health Disparities (CPHHD), hold promise for understanding the complex determinants of cancer disparities and their interactions as well as translating scientific discoveries into solutions. The CPHHD model maps across a range of scientific disciplines, from the biological to the social, each with its own disciplinary language and methods. The ability to work effectively across disciplinary boundaries is essential to framing comprehensive solutions. Methods: After briefly characterizing the current state of knowledge about health disparities, we outline three major challenges faced by disparities researchers and practitioners and offer suggestions for addressing these challenges. Results: These challenges are how to consider race and ethnicity in disparities research, how best to translate discoveries into public health solutions to cancer disparities, and how to create a research environment that supports the successful execution of multilevel research. Conclusions: Attention to all three of the challenges outlined above is urgently needed to advance our efforts to eliminate cancer disparities. Impact: Addressing the challenges outlined above will help to eliminate disparities in the future.Cancer Epidemiol Biomarkers Prev; 20(9); 1809–14. ©2011 AACR.